Advertisement

Pflügers Archiv

, 452:260 | Cite as

Resistin as a putative modulator of insulin action in the daily feeding/fasting rhythm

  • P. Oliver
  • J. Ribot
  • A. M. Rodríguez
  • J. Sánchez
  • C. Picó
  • A. Palou
Adaptation, Biorhythms

Abstract

Resistin and adiponectin are adipokines with postulated opposite functions. Resistin has been related with insulin resistance in obesity, while adiponectin could be associated to higher insulin sensitivity. We have determined whether the production of these two adipokines during the day is related to the feeding rhythm in rats. Resistin mRNA levels in adipose tissue correlated positively with the gastric contents and serum insulin concentration, showing higher levels during the dark phase (period of the highest food intake), especially in the mesenteric depot, while levels decreased during the light phase. The diurnal pattern of resistin expression was not directly reflected in the circulating levels, but it showed a 6-h delay and correlated negatively with the gastric contents and serum insulin. Adiponectin expression followed an opposite pattern, not apparently related to feeding or insulin release, and not translated into changes in circulating levels. Moreover, considering that insulin stimulates resistin expression and that circulating resistin follows a contrary circadian pattern in comparison to insulin, resistin, apart from its role in the increased insulin resistance associated to obesity, could also act as a putative modulator of insulin in the daily feeding/fasting rhythm through a negative feedback regulation of its action.

Keywords

Resistin Adiponectin Insulin action Circadian rhythm Feeding status 

Notes

Acknowledgements

This work was supported by the Spanish Government (grants G03/028, BFI2003-04439 and AGL 2004-07496/ALI). Our Laboratory is a member of the European Research Network of Excellence NuGO [The European Nutrigenomics Organization, EU Contract: FOOD-CT-2004-506360 NUGO (NOE)]. J.S. is a recipient of a fellowship from the Spanish Government.

References

  1. 1.
    Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413–437CrossRefPubMedGoogle Scholar
  2. 2.
    Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA (2004) Regulation of fasted blood glucose by resistin. Science 303:1195–1198CrossRefPubMedGoogle Scholar
  3. 3.
    Bertile F, Raclot T (2004) Differences in mRNA expression of adipocyte-derived factors in response to fasting, refeeding and leptin. Biochim Biophys Acta 1683:101–109PubMedGoogle Scholar
  4. 4.
    Bertile F, Oudart H, Criscuolo F, Maho YL, Raclot T (2003) Hypothalamic gene expression in long-term fasted rats: relationship with body fat. Biochem Biophys Res Commun 303:1106–1113CrossRefPubMedGoogle Scholar
  5. 5.
    Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn CR (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3:25–38CrossRefPubMedGoogle Scholar
  6. 6.
    Bogan JS, Lodish HF (1999) Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J Cell Biol 146:609–620CrossRefPubMedGoogle Scholar
  7. 7.
    Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O’Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE, Moller DE (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143:998–1007CrossRefPubMedGoogle Scholar
  8. 8.
    Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290:1084–1089CrossRefPubMedGoogle Scholar
  9. 9.
    Felipe F, Bonet ML, Ribot J, Palou A (2004) Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 53:882–889PubMedCrossRefGoogle Scholar
  10. 10.
    Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98:2005–2010PubMedCrossRefGoogle Scholar
  11. 11.
    Gavrila A, Peng CK, Chan JL, Mietus JE, Goldberger AL, Mantzoros CS (2003) Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab 88:2838–2843CrossRefPubMedGoogle Scholar
  12. 12.
    Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, Brichard SM (2001) Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 288:1102–1107CrossRefPubMedGoogle Scholar
  13. 13.
    Havel PJ (2004) Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53(Suppl 1):S143–S151PubMedCrossRefGoogle Scholar
  14. 14.
    Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595–1599PubMedGoogle Scholar
  15. 15.
    Kim KH, Lee K, Moon YS, Sul HS (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252–11256CrossRefPubMedGoogle Scholar
  16. 16.
    Kim KH, Zhao L, Moon Y, Kang C, Sul HS (2004) Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci U S A 101:6780–6785PubMedCrossRefGoogle Scholar
  17. 17.
    Kitagawa Y, Bujo H, Takahashi K, Shibasaki M, Ishikawa K, Yagui K, Hashimoto N, Noda K, Nakamura T, Yano S, Saito Y (2004) Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin. Diabetologia 47:1847–1853CrossRefPubMedGoogle Scholar
  18. 18.
    Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685CrossRefPubMedGoogle Scholar
  19. 19.
    Nogueiras R, Gualillo O, Caminos JE, Casanueva FF, Dieguez C (2003) Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes Res 11:408–414PubMedGoogle Scholar
  20. 20.
    Nogueiras R, Gallego R, Gualillo O, Caminos JE, Garcia-Caballero T, Casanueva FF, Dieguez C (2003) Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett 548:21–27CrossRefPubMedGoogle Scholar
  21. 21.
    Oliver P, Pico C, Martinez N, Bonet ML, Palou A (2000) In vivo effects of CGP-12177 on the expression of leptin and uncoupling protein genes in mouse brown and white adipose tissues. Int J Obes Relat Metab Disord 24:423–428PubMedCrossRefGoogle Scholar
  22. 22.
    Palou A, Serra F, Bonet ML, Pico C (2000) Obesity: molecular bases of a multifactorial problem. Eur J Nutr 39:127–144CrossRefPubMedGoogle Scholar
  23. 23.
    Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS (2004) Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53:1671–1679PubMedCrossRefGoogle Scholar
  24. 24.
    Ribot J, Felipe F, Bonet ML, Palou A (2001) Changes of adiposity in response to vitamin A status correlate with changes of PPAR gamma 2 expression. Obes Res 9:500–509PubMedCrossRefGoogle Scholar
  25. 25.
    Sanchez J, Oliver P, Pico C, Palou A (2004) Diurnal rhythms of leptin and ghrelin in the systemic circulation and in the gastric mucosa are related to food intake in rats. Pflugers Arch 448:500–506PubMedCrossRefGoogle Scholar
  26. 26.
    Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409:307–312CrossRefPubMedGoogle Scholar
  27. 27.
    Steppan CM, Wang J, Whiteman EL, Birnbaum MJ, Lazar MA (2005) Activation of SOCS-3 by resistin. Mol Cell Biol 25:1569–1575CrossRefPubMedGoogle Scholar
  28. 28.
    Sul HS (2004) Resistin/ADSF/FIZZ3 in obesity and diabetes. Trends Endocrinol Metab 15:247–249CrossRefPubMedGoogle Scholar
  29. 29.
    Ueno N, Dube MG, Inui A, Kalra PS, Kalra SP (2004) Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 145:4176–4184CrossRefPubMedGoogle Scholar
  30. 30.
    Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR Jr, Willson TM, Kliewer SA, Hotamisligil GS (2001) Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 276:25651–25653CrossRefPubMedGoogle Scholar
  31. 31.
    Winzell MS, Nogueiras R, Dieguez C, Ahren B (2004) Dual action of adiponectin on insulin secretion in insulin-resistant mice. Biochem Biophys Res Commun 321:154–160CrossRefPubMedGoogle Scholar
  32. 32.
    Wolf G (2003) Adiponectin: a regulator of energy homeostasis. Nutr Rev 61:290–292CrossRefPubMedGoogle Scholar
  33. 33.
    Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941–946PubMedCrossRefGoogle Scholar
  34. 34.
    Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295PubMedCrossRefGoogle Scholar
  35. 35.
    Yildiz BO, Suchard MA, Wong ML, McCann SM, Licinio J (2004) Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci U S A 101:10434–10439PubMedCrossRefGoogle Scholar
  36. 36.
    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432CrossRefPubMedGoogle Scholar
  37. 37.
    Zhang Y, Matheny M, Zolotukhin S, Tumer N, Scarpace PJ (2002) Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta 1584:115–122PubMedGoogle Scholar
  38. 38.
    Zhang Y, Guo K-Y, Diaz PA, Heo M, Leibel RL (2002) Determinants of leptin gene expression in fat depots of lean mice. Am J Physiol Regul Integr Comp Physiol 282:R226–R234PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • P. Oliver
    • 1
  • J. Ribot
    • 1
  • A. M. Rodríguez
    • 1
  • J. Sánchez
    • 1
  • C. Picó
    • 1
  • A. Palou
    • 1
  1. 1.Laboratory of Molecular Biology, Nutrition and Biotechnology, Department of Fundamental Biology and Health SciencesUniversity of the Balearic IslandsPalma de MallorcaSpain

Personalised recommendations